Have European Investors Missed the Exosome ‘Gold Rush’?
When Oxford-based Evox Therapeutics announced its €81.1M (£69.2M) Series C round in February, it signaled…
When Oxford-based Evox Therapeutics announced its €81.1M (£69.2M) Series C round in February, it signaled…
The Dutch biotech startup Lava Therapeutics launched onto the Nasdaq stock market last week with…
In the last decade, crowdfunding has become a popular way to finance all sorts of…
Companies developing sustainable meat and dairy alternatives smashed records with a €2.6B ($3.1B) haul last…
A €62M Series B round announced by the Belgian company AgomAb Therapeutics last week is…
In 2020, fundraising seems like an even bigger challenge than before. The biotech industry, however,…
Following 2018’s bumper harvest for equity funding in European biotech, 2019 proved even more lucrative,…
For a few decades, the worlds of biotech and digital technology have been on separate…
Italian technology transfer company AurorA-TT has joined forces with drug discovery companies Rottapharm Biotech and…
Traditionally European biotechs have looked to the US for additional investment, but changes in the…
Making one biotech a success is hard enough, but correctly predicting multiple winners is the…
Early-stage investments in the healthcare sector are often dominated by public money, which is directly…